Atherosclerosis predominantly affects regions of the arteries that bend or branch, creating disturbances in blood flow dynamics that activate cells’ inflammatory pathways and eventually lead to plaque buildup.
A Cleveland Clinic first-in-human clinical trial has shown that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe in reducing LDL (“bad”) cholesterol and triglycerides in people with medication-resistant lipid disorders through one year of follow-up across all doses.
ROTTERDAM, Netherlands, Sept. 3, 2026 /PRNewswire/ — United Imaging has received CE Mark certification for the uCT SiriuX and uCT SiriuX Ultrix, the world’s first dual wide-coverage computed tomography (CT) family, clearing the systems for commercial availability across Europe.
YORK, Pa., Sept. 3, 2026 /PRNewswire/ — HR HealthCare today announced the introduction of the Liv™ Pre-lubricated Intermittent Catheter, developed to support women’s bladder management needs. For many women, intermittent self-catheterization is part of daily life alongside work, family, travel, and social commitments. Liv combines protective features with a modern profile and packaging designed to fit into busy lives.
Heartvue.Proton is designed to streamline cardiovascular MRI evaluation.
A new Northwestern Medicine study has uncovered a biological mechanism that may explain why a subset of tumors unexpectedly grows at an accelerated rate after being treated with certain immunotherapies, according to findings published in the journal Cancer Discovery.
Mayo Clinic researchers tested an approach that uses artificial intelligence (AI) to help people without previous ultrasound experience capture heart images and identify patients who may have a common and serious heart valve condition.
A review by University of Manchester scientists says sophisticated lab-grown tumors could help fast-track the search for new cancer treatments while reducing reliance on animal testing.
Molecules called reactive oxygen species, which include so-called “free radicals,” have long been viewed as damaging byproducts of our body’s metabolism—a reason antioxidant supplements have been considered a potential way to reduce cancer risk.
New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions.